WFH/X
Jul 25, 2025, 05:11
Global Study Sheds Light on Low-Dose Prophylaxis in Hemophilia A
The World Federation of Hemophilia (WFH) shared a post on X:
“A new study using data from WAPPS-Hemo explores the use of low-dose prophylaxis (LDP). The findings show that lower-income countries are more likely to adopt LDP highlighting the urgent need for equitable access.”
Read the full article here.
Title: A Global Cross-Sectional Database Study of Low Dose FVIII SHL Prophylaxis in Haemophilia A
Authors: Dagmar M. Hajducek, Oceana Sinkovic, Pierre Chelle, Alfonso Iorio, Andrea Edginton
Stay informed with Hemostasis Today.
-
Feb 24, 2026, 12:53Tagreed Alkaltham։ Blood Is a Naturally Integrated and Adaptive Physiological System
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England